Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2000 Oct;5(4):379-91.
doi: 10.1023/a:1009577811584.

Xenograft models of premalignant breast disease

Affiliations
Review

Xenograft models of premalignant breast disease

F R Miller. J Mammary Gland Biol Neoplasia. 2000 Oct.

Abstract

Dysplastic and hyperplastic proliferative lesions with graded severity of atypia are recognized in a number of tissues and are generally suspected to be premalignant, that is to say at high risk for further progressing to carcinoma in situ and invasive cancer. However, few xenograft models of premalignancy for any organ site have been successfully developed. A good model of human premalignant breast disease would lead to lesions which resemble high risk human breast disease in xenografts and sporadically progress to invasive cancer with time. In this chapter the use of breast tissue pieces and epithelial cells for establishment of xenografts and the development of human breast epithelial cell lines that form premalignant xenograft lesions are described. MCF10AT cells not only form simple differentiated ducts which persist in xenografts and sporadically progress to carcinoma, but also form intermediate proliferative lesions resembling proliferative disease without atypia, atypical hyperplasia, and carcinoma in situ.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Anticancer Res. 1996 Jul-Aug;16(4A):1765-9 - PubMed
    1. Endocrinology. 1995 Jan;136(1):164-71 - PubMed
    1. Rapid Commun Mass Spectrom. 1999;13(18):1808-12 - PubMed
    1. Am J Pathol. 1986 Aug;124(2):199-206 - PubMed
    1. Int J Oncol. 1995 Oct;7(4):889-93 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources